These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8143171)

  • 1. [Advances in rheumatology].
    Dong Y
    Zhonghua Yi Xue Za Zhi; 1993 Dec; 73(12):716-7. PubMed ID: 8143171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear and perinuclear atibodies in rheumatology. Immunofluorescence studies].
    Marmont A; Damasio E
    G Mal Infett Parassit; 1968 Jan; 20(1):124-32. PubMed ID: 4880275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological advances in rheumatology].
    Astorga G
    Rev Med Chil; 1968 Feb; 96(2):103-10. PubMed ID: 4180981
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urgent problems of modern rheumatology].
    Nasonova VA
    Ter Arkh; 1975; 47(11):6-12. PubMed ID: 1083565
    [No Abstract]   [Full Text] [Related]  

  • 6. Tobacco smoking and autoimmune rheumatic diseases.
    Harel-Meir M; Sherer Y; Shoenfeld Y
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA-antigens and rheumatic diseases].
    Egeland T
    Tidsskr Nor Laegeforen; 1985 Jun; 105(19-21):1294-7. PubMed ID: 3874448
    [No Abstract]   [Full Text] [Related]  

  • 8. Appropriate laboratory testing in rheumatic diseases.
    Metzger AL; Morris RI
    Lippincotts Prim Care Pract; 1998; 2(1):52-65. PubMed ID: 9451199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical importance of complement research in rheumatic diseases].
    Tanner E; Wessel G
    Z Gesamte Inn Med; 1980 Dec; 35(24):191-2 contd. PubMed ID: 6971535
    [No Abstract]   [Full Text] [Related]  

  • 10. Smoking as a trigger for inflammatory rheumatic diseases.
    Klareskog L; Padyukov L; Alfredsson L
    Curr Opin Rheumatol; 2007 Jan; 19(1):49-54. PubMed ID: 17143096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and autoimmune rheumatic diseases.
    Cutolo M
    Rheumatology (Oxford); 2009 Mar; 48(3):210-2. PubMed ID: 18930963
    [No Abstract]   [Full Text] [Related]  

  • 12. [The predictive value of autoantibodies in disseminating lupus erythematosus and rheumatoid arthritis].
    Dijkmans BA; van Schaardenburg D; van der Horst-Bruinsma IE; Reesink HW; Vandenbroucke JP; Boers M
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):688-93. PubMed ID: 15819133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus.
    Rensch MJ; Szyjkowski R; Shaffer RT; Fink S; Kopecky C; Grissmer L; Enzenhauer R; Kadakia S
    Am J Gastroenterol; 2001 Apr; 96(4):1113-5. PubMed ID: 11316156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in systemic rheumatic disorders clinical and diagnostic relevance.
    Genth E; Mierau R
    Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):149S-152S. PubMed ID: 9385666
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies to calprotectin are not found in patients with systemic lupus erythematosus or other inflammatory rheumatic diseases.
    Wahren M; Brun JG; Jonsson R; Haga HJ
    Lupus; 1995 Dec; 4(6):498. PubMed ID: 8749577
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation.
    Massardo L; Metz C; Pardo E; Mezzano V; Babul M; Jarpa E; Guzmán AM; André S; Kaltner H; Gabius HJ; Jacobelli S; González A; Soza A
    Lupus; 2009 May; 18(6):539-46. PubMed ID: 19395456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ; Schur PH
    J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.